The Effects of Early Enteral Nutrition on Endoscopic Therapy of Esophagogastric Varices in Liver Cirrhosis
Investigation of the Effects of Early Enteral Nutrition on Endoscopic Therapy of Esophagogastric Varices in Liver Cirrhosis:An Observational Study
1 other identifier
observational
397
1 country
1
Brief Summary
The purpose of this study was to evaluate the safety of early enteral nutrition on endoscopic therapy of esophagogastric varices in Liver Cirrhosis ,and to assess the impact of different eating times on patients, so as to determine the best time for patients to obtain nutrition after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2020
CompletedFirst Submitted
Initial submission to the registry
February 4, 2021
CompletedFirst Posted
Study publicly available on registry
April 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 20, 2021
CompletedMarch 2, 2022
March 1, 2021
12 months
February 4, 2021
February 23, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
rebleeding
the rate of rebleeding after endoscopic therapy
2 to 30days
Study Arms (2)
early enteral nutrition support group
Nutrient solution is provided through oral nutrient solution within 4-48 hours after endoscopic treatment
parenteral Nutrition Group
Intravenous nutrition is provided within 48 hours after endoscopic treatment
Interventions
For the patients with esophageal and gastric varices after endoscopic treatment,start taking the nutrient solution at the fourth hour.
Eligibility Criteria
Patients with cirrhosis of gastroesophageal varices undergoing endoscopic
You may qualify if:
- Patients with cirrhosis of gastroesophageal varices undergoing endoscopic therapy
You may not qualify if:
- Endoscopic treatment of uncontrollable bleeding
- Accompanied with other endoscopic treatments that need to be fasting
- With obvious hepatic encephalopathy and liver failure
- Did not sign the informed consent form and refused to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Qilu Hospital , Shandong University
Jinan, Shandong, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gao Yanjing, PhD.MD
Qilu Hospital of Shandong University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 4, 2021
First Posted
April 1, 2021
Study Start
September 1, 2020
Primary Completion
August 30, 2021
Study Completion
October 20, 2021
Last Updated
March 2, 2022
Record last verified: 2021-03